MedTrace Logo

Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin Administration

NCT05584943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2022-10-18

No results posted yet for this study

Summary

Extracellular vesicles (EVs) are small vesicles deriving from all cell types during cell activation, involved in transcellular communication, and regarded as predictors of vascular damage and of cardiovascular events. The investigators will test the hypothesis that, in patients on chronic low-dose aspirin treatment for cardiovascular prevention, aspirin may affect the release of EVs within the 24 hours interval.

Conditions

Sponsors & Collaborators

  • G. d'Annunzio University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-21
Primary Completion
2017-05-09
Completion
2017-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05584943 on ClinicalTrials.gov